Trade Arcus Biosciences, Inc. - RCUS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.16 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023485% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001262% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 10.15 |
| Open | 10.7 |
| 1-Year Change | -45.21% |
| Day's Range | 9.9 - 10.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 25, 2025 | 10.15 | 0.02 | 0.20% | 10.13 | 10.40 | 9.95 |
| Feb 24, 2025 | 10.12 | -0.74 | -6.81% | 10.86 | 10.94 | 10.07 |
| Feb 21, 2025 | 11.03 | -0.33 | -2.90% | 11.36 | 11.39 | 10.73 |
| Feb 20, 2025 | 10.67 | -0.18 | -1.66% | 10.85 | 11.01 | 10.57 |
| Feb 19, 2025 | 11.00 | -0.18 | -1.61% | 11.18 | 11.63 | 10.88 |
| Feb 18, 2025 | 10.91 | -1.73 | -13.69% | 12.64 | 12.81 | 10.58 |
| Feb 14, 2025 | 13.04 | 0.29 | 2.27% | 12.75 | 13.42 | 12.64 |
| Feb 13, 2025 | 12.61 | 0.71 | 5.97% | 11.90 | 12.68 | 11.76 |
| Feb 12, 2025 | 11.90 | 0.31 | 2.67% | 11.59 | 11.97 | 11.59 |
| Feb 11, 2025 | 11.88 | -0.37 | -3.02% | 12.25 | 12.40 | 11.83 |
| Feb 10, 2025 | 12.43 | -0.03 | -0.24% | 12.46 | 12.69 | 12.17 |
| Feb 7, 2025 | 12.50 | -0.46 | -3.55% | 12.96 | 12.97 | 12.46 |
| Feb 6, 2025 | 12.93 | -0.63 | -4.65% | 13.56 | 13.61 | 12.90 |
| Feb 5, 2025 | 13.48 | 0.48 | 3.69% | 13.00 | 13.68 | 13.00 |
| Feb 4, 2025 | 13.30 | 0.32 | 2.47% | 12.98 | 13.62 | 12.91 |
| Feb 3, 2025 | 13.17 | 0.73 | 5.87% | 12.44 | 13.42 | 12.44 |
| Jan 31, 2025 | 12.80 | -0.44 | -3.32% | 13.24 | 13.40 | 12.80 |
| Jan 30, 2025 | 13.27 | 0.32 | 2.47% | 12.95 | 13.51 | 12.91 |
| Jan 29, 2025 | 12.92 | 0.01 | 0.08% | 12.91 | 13.27 | 12.77 |
| Jan 28, 2025 | 13.01 | -0.36 | -2.69% | 13.37 | 13.37 | 12.99 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Arcus Biosciences, Inc. Company profile
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing cancer therapies in the United States. The company''s product pipeline includes, AB928, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 monoclonal antibody that is in Phase Ib clinical trial for monotherapy. It is also developing AB154, an anti-TIGIT monoclonal antibody, which is in Phase 2 development for the treatment of first-line metastatic non-small cell lung cancer in combination with Zimberelimab and AB928; and AB680, small-molecule CD73 inhibitor is in a Phase 1/1b study for the treatment of first-line metastatic pancreatic cancer. Arcus Biosciences, Inc. has a clinical development collaboration agreement with Strata Oncology, Inc. to evaluate Zimberelimab; license agreements with Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC, and WuXi Biologics (Cayman) Inc.; and co-development and co-commercialization partnership with Gilead Sciences, Inc. for the development of cancer immunotherapies. The company was founded in 2015 and is based in Hayward, California.| Industry: | Biotechnology & Medical Research (NEC) |
3928 Point Eden Way
HAYWARD
CALIFORNIA 94545-3719
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com